NL-OMON26416Other不适用
TOLERANCE OF DOLUTEGRAVIR VERSUS RALTEGRAVIR COMBINED WITH TENOFOVIR DISOPROXIL AND EMTRICITABINE OR LAMIVUDINE AS POSTEXPOSURE PROPHYLAXIS AGAINST HIV INFECTIO
niversity Medical Centrum Utrecht0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- Other
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Indication for start of postexposure prophylaxis with either DTG or RAL,
- •next to two NRTI agents which will be prescribed by the attending
- •physician at presentation
排除标准
- •-pregnancy
- •-lactation
研究者
相似试验
进行中（未招募）
1 期
Comparison between a Raltegravir-based treatment versus a raltegravir-based treatment plus atorvastatin for reducing aging-related inflamation in HIV-infected patients older than 60 years.EUCTR2015-002682-30-ESFundació Lluita contra la SIDA60
招募中
2 期
Evaluation of the effect of an antiretroviral drug in patients infected with HTLV-1.Human T-lymphotropic virus 1B04RBR-5x7ccxpFundação Bahiana de Infectologia - FBA
尚未招募
3 期
Evaluation the effect of raltegravir, and raltegravir/interferon beta combination on covid 19 patientsIRCT20200412047042N1Jahrom University of Medical Sciences60
招募中
不适用
Evaluation of use of Dolutegravir in children aged 6 to 12 years: a multicenter study in BrazilHuman immunodeficiency virus (HIV) disease resulting in infectious and parasitic diseasesRBR-87x8h69Faculdade de Medicina, Universidade Federal de Minas Gerais/UFMG
招募中
不适用
Comparison of Liraglutide vs. Dulaglutide in type 2 diabetic outpatients using Flash Glucose monitoring (FGM)JPRN-UMIN000030624Kitasato University School of Pharmacy60